Zymergen to Present at the 40th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Zymergen Inc. announced its participation in the 40th Annual J.P. Morgan Virtual Healthcare Conference, taking place on January 10th, 2022, at 2:15 p.m. ET. The conference presentation will be accessible via a live and archived webcast on the company's website. Zymergen focuses on designing and producing innovative molecules, microbes, and materials, aligning its mission with sustainability and improved product offerings.
Positive
- None.
Negative
- None.
News Market Reaction – ZY
In the trading session that priced this news, ZY gained 0.18%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”or the “Company”), today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Virtual Healthcare Conference.
Zymergen’s management is scheduled to present on Monday, January 10th at 2:15 p.m. Eastern Time/11:15 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.zymergen.com/.
About Zymergen
Zymergen is a biotech company that designs and produces molecules, microbes and materials for diverse end markets. We partner with nature to make better products, a better way, for a better world.
Investor Contact
Carrie Mendivil
investors@zymergen.com
Media Contact
Mike Dulin
mdulin@zymergen.com
